Premier Alternatives

Kailera Therapeutics (NAS: KLRA)

Waltham, MA · Founded 2024 · Publicly Held

Kailera Therapeutics Inc is a clinical-stage biotechnology company. Kailera Therapeutics (NAS: KLRA) is based in Waltham, MA and was founded in 2024. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Oct 2025). It has raised $1.6 billion.

Last price · $/share
—
Implied valuation
$1.5B
Total raised
$1.6B
Last round
—
How much has Kailera Therapeutics (NAS: KLRA) raised?
$1.6Bacross 0 recorded rounds
Free account
More of Kailera Therapeutics (NAS: KLRA) with a free account
  • ·The complete investor list: 14 names
  • ·Watch Kailera Therapeutics (NAS: KLRA): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kailera Therapeutics (NAS: KLRA) investors

14 investors are on record for Kailera Therapeutics (NAS: KLRA), including Qatar Investment Authority, Bain Capital, The Invus Group and RTW Investments. By type, the record holds 4 hedge funds, 2 private equity firms and 1 venture capital firm.

For fundraisers
Raising for a company like Kailera Therapeutics (NAS: KLRA)?

14 investors have backed Kailera Therapeutics (NAS: KLRA).

See all 14 investors →

Frequently asked about Kailera Therapeutics (NAS: KLRA)

How much has Kailera Therapeutics (NAS: KLRA) raised?
Kailera Therapeutics (NAS: KLRA) has raised $1.6B in total across 0 recorded funding rounds.